Výsledky vyhledávání - Torrea, Gabriela
- Zobrazuji výsledky 1 - 17 z 17
-
1
Efficient Tracing of Global Isolates of Yersinia pestis by Restriction Fragment Length Polymorphism Analysis Using Three Insertion Sequences as Probes Autor Torrea, Gabriela, Chenal-Francisque, Viviane, Leclercq, Alexandre, Carniel, Elisabeth
Vydáno 2006Text -
2
-
3
-
4
Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis Autor Goodall, Ruth L., Sanders, Karen, Bronson, Gay, Gurumurthy, Meera, Torrea, Gabriela, Meredith, Sarah, Nunn, Andrew, Rusen, I. D.
Vydáno 2022Text -
5
Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results Autor Ng, Kamela Charmaine, Meehan, Conor Joseph, Torrea, Gabriela, Goeminne, Léonie, Diels, Maren, Rigouts, Leen, de Jong, Bouke Catherine, André, Emmanuel
Vydáno 2018Text -
6
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled t... Autor Nunn, Andrew J, Rusen, ID, Van Deun, Armand, Torrea, Gabriela, Phillips, Patrick PJ, Chiang, Chen-Yuan, Squire, S Bertel, Madan, Jason, Meredith, Sarah K
Vydáno 2014Text -
7
Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations Autor Ng, Kamela C. S., van Deun, Armand, Meehan, Conor J., Torrea, Gabriela, Driesen, Michèle, Gabriëls, Siemon, Rigouts, Leen, André, Emmanuel, de Jong, Bouke C.
Vydáno 2018Text -
8
Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings Autor Van Deun, Armand, Bola, Valentin, Lebeke, Rossin, Kaswa, Michel, Hossain, Mohamed Anwar, Gumusboga, Mourad, Torrea, Gabriela, De Jong, Bouke Catharine, Rigouts, Leen, Decroo, Tom
Vydáno 2022Text -
9
A Multimethod, Multicountry Evaluation of Breakpoints for Bedaquiline Resistance Determination Autor Ismail, Nazir Ahmed, Aono, Akio, Borroni, Emanuele, Cirillo, Daniela Maria, Desmaretz, Christel, Hasan, Rumina, Mitarai, Satoshi, Shakoor, Sadia, Torrea, Gabriela, Kaniga, Koné, Omar, Shaheed V.
Vydáno 2020Text -
10
Diagnostic performance of smear microscopy and incremental yield of Xpert in detection of pulmonary tuberculosis in Rwanda Autor Ngabonziza, Jean Claude Semuto, Ssengooba, Willy, Mutua, Florence, Torrea, Gabriela, Dushime, Augustin, Gasana, Michel, Andre, Emmanuel, Uwamungu, Schifra, Nyaruhirira, Alaine Umubyeyi, Mwaengo, Dufton, Muvunyi, Claude Mambo
Vydáno 2016Text -
11
Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda Autor Ssengooba, Willy, de Dieu Iragena, Jean, Komakech, Kevin, Okello, Iginitius, Nalunjogi, Joanitah, Katagira, Winceslaus, Kimuli, Ivan, Adakun, Susan, Joloba, Moses L, Torrea, Gabriela, Kirenga, Bruce J
Vydáno 2021Text -
12
Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda Autor Ssengooba, Willy, Komakech, Kevin, Namiiro, Sharon, Byabajungu, Henry, Nalunjogi, Joanitah, Katagira, Winceslaus, Kimuli, Ivan, Joloba, Moses L, Adakun, Susan, Nakiyingi, Lydia, Torrea, Gabriela, Kirenga, Bruce J
Vydáno 2021Text -
13
Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study Autor Kaniga, Koné, Aono, Akio, Borroni, Emanuele, Cirillo, Daniela Maria, Desmaretz, Christel, Hasan, Rumina, Joseph, Lavania, Mitarai, Satoshi, Shakoor, Sadia, Torrea, Gabriela, Ismail, Nazir Ahmed, Omar, Shaheed V.
Vydáno 2020Text -
14
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard Autor Van Deun, Armand, Aung, Kya J. M., Bola, Valentin, Lebeke, Rossin, Hossain, Mohamed Anwar, de Rijk, Willem Bram, Rigouts, Leen, Gumusboga, Aysel, Torrea, Gabriela, de Jong, Bouke C.
Vydáno 2013Text -
15
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance Autor Torrea, Gabriela, Ng, Kamela C. S., Van Deun, Armand, André, Emmanuel, Kaisergruber, Justine, Ssengooba, Willy, Desmaretz, Christel, Gabriels, Siemon, Driesen, Michèle, Diels, Maren, Asnong, Sylvie, Fissette, Kristina, Gumusboga, Mourad, Rigouts, Leen, Affolabi, Dissou, Joloba, Moses, De Jong, Bouke C.
Vydáno 2019Text -
16
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial Autor Goodall, Ruth L, Meredith, Sarah K, Nunn, Andrew J, Bayissa, Adamu, Bhatnagar, Anuj K, Bronson, Gay, Chiang, Chen-Yuan, Conradie, Francesca, Gurumurthy, Meera, Kirenga, Bruce, Kiria, Nana, Meressa, Daniel, Moodliar, Ronelle, Narendran, Gopalan, Ngubane, Nosipho, Rassool, Mohammed, Sanders, Karen, Solanki, Rajesh, Squire, S Bertel, Torrea, Gabriela, Tsogt, Bazarragchaa, Tudor, Elena, Van Deun, Armand, Rusen, ID
Vydáno 2022Text -
17
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century Autor Ngabonziza, Jean Claude S., Rigouts, Leen, Torrea, Gabriela, Decroo, Tom, Kamanzi, Eliane, Lempens, Pauline, Rucogoza, Aniceth, Habimana, Yves M., Laenen, Lies, Niyigena, Belamo E., Uwizeye, Cécile, Ushizimpumu, Bertin, Mulders, Wim, Ivan, Emil, Tzfadia, Oren, Muvunyi, Claude Mambo, Migambi, Patrick, Andre, Emmanuel, Mazarati, Jean Baptiste, Affolabi, Dissou, Umubyeyi, Alaine N., Nsanzimana, Sabin, Portaels, Françoise, Gasana, Michel, de Jong, Bouke C., Meehan, Conor J.
Vydáno 2022Text